Feds Issue Warnings on 'Copycat' Delta-8 Products That Mimic Popular Foods
Medically reviewed by Drugs.com.
By Robin Foster HealthDay Reporter
WEDNESDAY, July 17, 29024 -- In a joint effort to curb the illegal sales of food products containing delta-8 THC, the U.S. Food and Drug Administration and the Federal Trade Commission said Tuesday they have warned five companies to stop marketing such products.
Because the packaging for these THC edibles mimics that of popular snack foods, the FDA said it is concerned they can be easily mistaken for traditional foods, prompting accidental ingestion or overconsumption, especially by kids.
“Inadequate or confusing labeling can result in children or unsuspecting adults consuming products with strong resemblance to popular snacks and candies that contain delta-8 THC without realizing it,” FDA Principal Deputy Commissioner Dr. Namandjé Bumpus said in a news release on the warnings.
Delta-8 THC is the psychoactive ingredient in the cannabis sativa plant, of which marijuana and hemp plants are two varieties.
The FDA said it has given the companies 15 working days to address the violations and prevent future ones.
Last summer, the agencies issued similar warnings to six other companies selling products containing delta-8 THC, and those companies no longer have such products in stock, the agencies noted.
A spokesperson for Earthly Hemps, one of the companies issued a warning Tuesday, told CNN that it has not sold any of the products this year. The other companies did not respond to a request for comment.
The threat these "copycat" products pose is real: From Jan. 1, 2021, to Dec. 31, 2023, the FDA said it has received over 300 adverse event reports involving children and adults who consumed delta-8 THC products. That led the agency to issue its first warning to customers in June 2022.
The adverse effects included hallucinations, vomiting, tremor, anxiety, dizziness, confusion and loss of consciousness, the agency said. Nearly half of the cases involved hospitalization or emergency room visits.
“Companies that market and sell edible THC products that are easily mistaken for snacks and candy are not only acting illegally, but they are also putting the health of young children at risk,” Samuel Levine, director of the FTC’s Bureau of Consumer Protection, said in the FDA news release. “Those that prioritize profits in front of children’s safety are at serious risk of legal action.”
Adverse reactions can be reported to the FDA using MedWatch or the Safety Reporting Portal.
“As accidental ingestion and/or overconsumption of delta-8 THC containing products could pose considerable health risks, the companies who sell these illegal products are demonstrating complete neglect for consumer safety,” Bumpus noted.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-07-17 23:15
Read more
- Lack of Insurance Could Mean Later Cancer Diagnoses for Black, Hispanic Americans
- Expanding Access to Obesity Medications Could Avert 42,000 Deaths/Year
- Medicaid Covers GLP-1 Meds for Obesity in Just 13 States
- Using Abortion Pills Very Early in Pregnancy Is Safe, Study Finds
- Weight-Loss Surgery for Teens Brings Lasting Benefit
- Monthly News Roundup - October 2024
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions